158 related articles for article (PubMed ID: 26161668)
1. Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes.
Jin Y; Elalaf H; Watanabe M; Tamaki S; Hineno S; Matsunaga K; Woltjen K; Kobayashi Y; Nagata S; Ikeya M; Kato T; Okamoto T; Matsuda S; Toguchida J
PLoS One; 2015; 10(7):e0131998. PubMed ID: 26161668
[TBL] [Abstract][Full Text] [Related]
2. IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci's Syndrome.
Cheng P; Chen K; Zhang S; Mu KT; Liang S; Zhang Y
Front Endocrinol (Lausanne); 2021; 12():763349. PubMed ID: 34790172
[TBL] [Abstract][Full Text] [Related]
3. Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report.
Lv H; Jiang H; Zhang M; Luo H; Hong Z; Yang H; Xu W; Shen B; Zhang W; Qiu H; Zhu R
World J Surg Oncol; 2022 Jun; 20(1):218. PubMed ID: 35765075
[TBL] [Abstract][Full Text] [Related]
4. Maffucci syndrome complicated by three different central nervous system tumors sharing an IDH1 R132C mutation: case report.
Nejo T; Tanaka S; Ikemura M; Nomura M; Takayanagi S; Shin M; Ushiku T; Shibahara J; Saito N; Mukasa A
J Neurosurg; 2018 Dec; 131(6):1829-1834. PubMed ID: 30579273
[TBL] [Abstract][Full Text] [Related]
5. Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis.
Johannessen TA; Mukherjee J; Viswanath P; Ohba S; Ronen SM; Bjerkvig R; Pieper RO
Mol Cancer Res; 2016 Oct; 14(10):976-983. PubMed ID: 27430238
[TBL] [Abstract][Full Text] [Related]
6. Atypical cartilage in type II germ cell tumors of the mediastinum show significantly different patterns of IDH1/2 mutations from conventional chondrosarcoma.
Warmke LM; Cheng L; Sperling RM; Sen JD; Ulbright TM
Mod Pathol; 2022 Nov; 35(11):1636-1643. PubMed ID: 35660795
[TBL] [Abstract][Full Text] [Related]
7. Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation.
Pathmanapan S; Poon R; De Renshaw TB; Nadesan P; Nakagawa M; Seesankar GA; Ho Loe AK; Zhang HH; Guinovart JJ; Duran J; Newgard CB; Wunder JS; Alman BA
Cell Rep; 2023 Jun; 42(6):112578. PubMed ID: 37267108
[TBL] [Abstract][Full Text] [Related]
8. Distinct IDH1/2-associated Methylation Profile and Enrichment of
Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
[TBL] [Abstract][Full Text] [Related]
9. IDH1 Mutation Induces HIF-1
Hu X; Li L; Eid JE; Liu C; Yu J; Yue J; Trent JC
Dis Markers; 2022; 2022():7729968. PubMed ID: 35198082
[TBL] [Abstract][Full Text] [Related]
10. Distinct Roles of Glutamine Metabolism in Benign and Malignant Cartilage Tumors With IDH Mutations.
Zhang H; Puviindran V; Nadesan P; Ding X; Shen L; Tang YJ; Tsushima H; Yahara Y; Ban GI; Zhang GF; Karner CM; Alman BA
J Bone Miner Res; 2022 May; 37(5):983-996. PubMed ID: 35220602
[TBL] [Abstract][Full Text] [Related]
11. AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma.
Zheng D; Liu W; Xie W; Huang G; Jiang Q; Yang Y; Huang J; Xing Z; Yuan M; Wei M; Li Y; Yin J; Shen J; Shi Z
Signal Transduct Target Ther; 2021 Jan; 6(1):25. PubMed ID: 33468990
[TBL] [Abstract][Full Text] [Related]
12. Genetics and epigenetics in conventional chondrosarcoma with focus on non-coding RNAs.
Roessner A; Franke S; Schreier J; Ullmann S; Karras F; Jechorek D
Pathol Res Pract; 2022 Nov; 239():154172. PubMed ID: 36274381
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds.
Wu F; Jiang H; Zheng B; Kogiso M; Yao Y; Zhou C; Li XN; Song Y
J Med Chem; 2015 Sep; 58(17):6899-6908. PubMed ID: 26280302
[TBL] [Abstract][Full Text] [Related]
14. Ovarian juvenile granulosa cell tumors with Ollier's disease in children with IDH1 gene somatic mutation.
Zhang J; Hua R; Ma L; Liu C; Zhang Y; Lü X; Wang T; Wan N
Front Endocrinol (Lausanne); 2023; 14():1093273. PubMed ID: 37324278
[TBL] [Abstract][Full Text] [Related]
15. Diagnostics of
Varachev V; Shekhtman A; Guskov D; Rogozhin D; Zasedatelev A; Nasedkina T
Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248076
[TBL] [Abstract][Full Text] [Related]
16. An activating germline
Blackburn PR; Carter JM; Oglesbee D; Westendorf JJ; Neff BA; Stichel D; Tsen DW; Gavrilova RH; Wesseling P; von Deimling A; Caulfield TR; Klee EW; Pusch S; Inwards CY
HGG Adv; 2020 Oct; 1(1):100006. PubMed ID: 35047830
[TBL] [Abstract][Full Text] [Related]
17. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
[TBL] [Abstract][Full Text] [Related]
18. Vulnerability of IDH1-Mutant Cancers to Histone Deacetylase Inhibition via Orthogonal Suppression of DNA Repair.
Dow J; Krysztofiak A; Liu Y; Colon-Rios DA; Rogers FA; Glazer PM
Mol Cancer Res; 2021 Dec; 19(12):2057-2067. PubMed ID: 34535560
[TBL] [Abstract][Full Text] [Related]
19.
Chen C; Li J; Jiang T; Tang J; Zhang Z; Luo Y; Wang X; Sun K; Jiang Z; Zhou J; Liu Z
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428825
[TBL] [Abstract][Full Text] [Related]
20. CORR Insights®: Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone?
Ramsey DC
Clin Orthop Relat Res; 2024 Jun; 482(6):957-959. PubMed ID: 38446419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
